高血脂症的诊断和治疗 - newworldtimes.us · 大多数高血脂症的患者都没有临床 症状。但高血脂症会导致心脏冠状 动脉血管内壁增厚和硬化,从而使
成分输血的临床应用 山东省血液中心 王爱梅
description
Transcript of 成分输血的临床应用 山东省血液中心 王爱梅
-
1900ABO70%50%
-
1.11 31011/L1250ml3000ml23PC 2235VIIIVIX-2014
-
90% 99%42.89% 39.96%11.96% 4.69%0.5%29.26% 40.77%28.09% 1.88%
-
98%29.26% 40.77%28.09% 1.88%95%95%,,,,
-
3.11. 26400HLA150
-
80%95%
-
3.23.2.1. ATPK
-
3.2.2. ACD21 CPD-A35
-
ACDCPDACDCPD35PH23-DPGATP
-
3.2.322+23.2.483.2.5VIII2450%V3550%3.2.6
-
3.33.3.13.3.23.3.3
-
3.3.4,99.99%
-
3.43.4.13.4.2,123.4.383.4.4
-
3.53.5.1 4723.5.210HTLV-I/II,0-574%6-1044%11-140%3.5.3 143.5.4
-
3.6 3ACD7CPD3.6.1 CPD4 47CPD3ACD23DPG99%CPD41
-
1 CPD4 0 7 14 21 28 100 98 85 80 75 PH 7.2 7.0 6.9 6.8 6.8 ATP 100 96 83 86 752,3-DPG 100 99 80 44 35 3.9 11.9 17.2 21 22.5 168 166 163 156 154 Hb 1.7 7.8 12.5 19.1 28.9NH3 165.3 176.2 262.5 293.6 414.0
-
3.73.7.13.7.2
-
3.7.3200-400ml/1017
-
6010
-
600ml
-
3.8
-
95% 20%-30%60%()3-4
-
4.14.1.1.MAPHCT60%21354.1.295%99.9%,,IgAIgA25-35HBV
-
4.1.399%4.1.3.1 1HLA2CMV34564.1.4601500-3000rad
-
4.1.5 -801037NaCl244.1.644.92910%-50%
-
5488
-
5.1 5.1.1. CMVEBTHTLV-1/2HBVHCVHIV5.1.2. Bodey5.1.3.G-CSF
- 66.1.1.2.41010/,25-30ml/(200ml)6.1.2. ,,2.5-31011/,200ml,,6.1.3
-
6.1.4.HLA 6.2.6.2.16.2.2DIC6.2.3
-
6.36.3.150109/L
-
6.450-70109/L6.5 =XX2.5 M2=1+[Kg+cm160] /100 2.5M2 / L
-
6.6CC16.6.1CC1=[-M2]1011 1011 /L1-CC110 CC1=[50109 /L-20109 /L1.7]31011 =51109 31011 =17
-
6.6.2%=-/LL2/3 2/31/3160%2440%%=[50109 /L-20109 /L4.83L] 31011 2/3 =144.5109 /L31011 =0.73=kg69 / 65 70 kg69
-
6.7HLA6.86.8.11/330%3u/10Kg
-
6.8.2 3u/10Kg6.8.3DIC3-4u/10Kg6.8.4
-
6.96.9.1.223-5 6.9.26.9.3
-
7.7.14-6307.2NIH7.2.1 .
-
7.2.2.7.2.3.IIVIIIXXIIVIIIXX2.57.2.4. 7.2.5. III7.2.6.
-
7.312-15ml/Kg7.42550100125200250ml8200ml400ml500-4IVIIIVIIIIbGPIbVIIIvWF
-
IIII8.1/400mlVIII FVIIIC 80Iu vWF >60IuF VIII ( FI ) 200-300mg ( FXII ) >80Iu ( FN ) >60mg
-
8.2 8.2.18.2.2DIC8.2.3FNFNFNFNDIC8.2.4 .
-
FN
-
8.3. FVIII50%FVIII30% FVIII128-121/2
-
8.4 VIII /Kg /Kg 1 15 10 10 1-21 25 10 10 1-2 25 10 10 25 25 15 10 35 25 15 10 >15 25 15 10 35 30 20 810 35 30 20 810 510 50 25 810 35 50 25 810 1015
-
99.19.1.19.1.1.1HbHb
-
129.2.1 15g/L
-
9.2.2 9.2.3 7
-
9.2.4
-
9.2.5 100g/LHCT0.27Hb130g/LHCT>0.3510-20ml/Kg1-2u1-2ml/min1-1.51-4
-
9.2.6 O1u/95%99%AB
-
9.2.7 9.2.8
-
9.2.9GVHD
-
9.3
-
9.3.120%DIC
- 9.3.29.3.2.1 Hb
-
9.3.9.3.1 2/323-Hb9.3.23-DPGO223-DPGO2O2
-
9.3.2 HCT60%4-623-DPGATGVHD
-
9.4.9.4.1. 4-53-49.4.2.
-
9.4.3. 1109/L0.1-0.5109/L25%9.4.4. 20109/L10109/L92%
- 9.4.5. 9.4.5.1
-
2-4u/9.4.5.3 T
-
9.4.5.4
5.4.1 5.4.2
-
4 =[WtVHb-Hb]HbWtKg V0.07L/ Kg0.085L/ KgHb24g20060KgHb60g/LHb100g/L
-
=[600.07100-60]24=7200724Hb
-
9.5=[WtVHb-Hb]Hb100% >80% >50-79% 20-50%
-
9.7GVHDGVHD,417-22RhRh6-82
-
T
-
9.8 GVHD9.8.19.8.29.8.3HLARabHLADaaRab/DaaTAGVHD
-
1218219.8. 4TAGVHDTAGVHDDNA
-
104-105/TA-GVHD
-
10.10.1 10.1.1
-
10.1.2
-
10.1.311000ml20%HCT32-35%21321000-2000ml20-40%11000-2000ml4-8310.5
-
340%5%3000ml1000ml400ml4-81000ml
-
10.210.2.1HCT(ml)=HCT-HCTHCT7%10.2.210.2.2.1
-
10.2.2.2 =0.7ml/kg/h7ml/kg/h HCT30-35%HCT
-
10.3 10.3.175kg11250109/L80109/L60109/L4-58-103-43-5
-
10.3.260109/L
-
10.3.314IgG0.4-0.5 ml /kg3-5IgG
-
10.3.4 4IgG4
-
10.3.5DICDICDICVVIII3P10.3.65-8PL-A1PL-A1PL-A1PL-A1
-
1111.1 11.1. 1 600ml 11.1.2 40%40%1/3
-
11.2 11.2.1.(1):(2)12(3)24(4),(5)38(6)30%11.2.2 100ml3.8%15ml50mg
-
11.3 11.3.1 Hb70g/ L11.3.2 2uRcc3100g/ L
-
11.4 HCT 11.4. 1. 21.3/14.6kpa++ ~+++>35%11.4. 2. AT-III
-
11.5DIC11.5.1.11.5.2.311.5.3.DICDICDICDICDIC
-
11.6DICDICIIIDIC
- 11.6.1
- 4.2DIC
-
1212.112.1.1 5.0-7.01012/L Hb 150-220g/LHb 10g/L2-3Hb110g/L12.1.2. 20109 /L10109/L6~612.1.3.
-
12.1.4. 85ml/kg108ml/kg75-150ml100ml50%1090%12.1.5. 4126 ml/kg89ml/lkgHCT48%64%Hb
-
12.212.2.1. 15%12.2.2. 5%310.510-20ml/kg/0.5-1.5ml/min245-10ml/kg/0.25-0.75 ml/min5ml/kg /(dl)= [Hb(g)Hb(g)]0.9Kg100mlHb(g):38g12g100ml20g12-80.90.320=0.54(dl)
-
12.2.330-32310/5/20-30ml10-25ml//
-
12.312.3.1. 12.3.1.1OAB25-35
-
12.3.1.2 IC3b95%500-100012.3.1.3 T12.3.2 ITPITP
-
12.3.2.1 100109/L 50109/L 20109/L 12.3.2.22-312.3.2.32-3/12.3.2.4 10109/L0.032/Kg/ 0.028/Kg/Rh12.3.2.5 200ml2.41010/ 31011/(15-16)
-
12.3.3. K12.3.3.1
-
VIII
u/100ml u/kg() 15-2020-408-1410-25
80 35-50
-
VIII12VIII4-5122-3
-
12.3.4. 12.3.4.1 12.3.4.2 10-25ml/kg/12.3.4.3 10-20/12.3.5. 1g13-14ml1812.3.5.1 5%10-25ml/kg/12.3.5.2 5%10-20/12.3.5.3(1) (2) 20-25%(3) 0.011%
-
12.3.6. 12.3.6.1 (1)(2)(3)(4)RhODRhODIgG(5)
-
12.3.6.2 IgG2-4g/L100mg/kg0.6mg/kg3-40.02-0.1ml/kg;0.06ml/kg250-500Iu;500-1000Iu;0.05-0.2ml/;20Iu;Rho(D)Rho(D)300ug ;1ml/;(ITP) 0.05g/200ml2,5
-
12.3.6.3 300.01-0.02ml/Kg,,0.02-0.04 ml/Kg,30,50-100mg,